12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Yervoy ipilimumab regulatory update

Bristol-Myers said the European Commission approved an application to expand the label of Yervoy ipilimumab to include previously untreated patients with unresectable...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >